期刊文献+

罗格列酮氧钒配合物的合成及表征 被引量:4

Synthesis and Characterization of Rosiglitazone Oxovanadium Complexes
原文传递
导出
摘要 目的:合成罗格列酮氧钒配合物并进行表征。方法:取罗格列酮与五水硫酸氧钒(VOSO4·5H2O)在适当的条件下(溶剂为乙醇,反应pH值为6)合成罗格列酮氧钒配合物,运用核磁共振氢谱和红外光谱等分析方法对配合物的结构进行了初步确证。结果与结论:确证形成了新的化合物即罗格列酮氧钒配合物,配合物中罗格列酮的化学结构未发生变化,其中2个氧钒均与1个罗格列酮和3个水分子结合。 OBJECTIVE: To synthesize and characterize new Rosiglitazone oxovanadium complexes. METHODS: Rosiglitazone oxovanadium complex was synthesized with rosiglitazone and VOSO,. 5H20 under suitable condition (ethanol was solvent, pH= 6). The structures were characterized by IR and 1H-NMR spectra. RESULTS & CONCLUSIONS: Results of study confirm that new compound is Rosiglitazone oxovanadium complex. The chemical structure of rosiglitazone has no change. Two oxovanadium cations always combine with one rosiglitazone and three water molecules in Rosiglitazone oxovanadium complexes.
出处 《中国药房》 CAS CSCD 北大核心 2011年第45期4253-4255,共3页 China Pharmacy
关键词 罗格列酮 氧钒 配合物 合成 表征 Rosiglitazone Oxovanadium Complex Synthesis Characterization
  • 相关文献

参考文献5

  • 1杨晓改,杨晓达,王夔.钒化合物生物效应的化学基础和药用前景——金属药物研究的化学问题[J].化学进展,2002,14(4):279-286. 被引量:19
  • 2Peters KG, Davis MG, Howard BW, et al. Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium) ; unliganded vanadium (VO4) as the active component[J]. Jlnorg Biochem, 2003,96 (2-3) : 321.
  • 3Thompson KH, Orvig C. Vanadium in diabetes: 100 years from Phase 0 to Phase I [J]. J lnorg Biochem, 2006, 100(12):1 925.
  • 4Yoram Shechter, Itzhak Goldwaser, Marina Mironchik, et al. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes[J]. Coordination Chemistry Reviews, 2003,237 ( 1 ) : 3.
  • 5安丽荣 霍雯 常艳玲 等.氧钒配合物的生物活性研究及其量化计算.西北大学学报,2004,.

二级参考文献5

  • 1Jianping Ye,Min Ding,Stephen S. Leonard,Victor A. Robinson,Lyndell Millecchia,Xiaoying Zhang,Vince Castranova,Val Vallyathan,Xianglin Shi. Vanadate induces apoptosis in epidermal JB6 Pplus cells via hydrogen peroxide-mediated reactions[J] 1999,Molecular and Cellular Biochemistry(1-2):9~17
  • 2Boyan Zhang,Li Ruan,Baowei Chen,Jinfen Lu,Kui Wang. Binding of vanadate to human erythrocyte ghosts and subsequent events[J] 1997,BioMetals(4):291~298
  • 3Debbie C. Crans,Mohammed Mahroof-Tahir,Anastasios D. Keramidas. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents[J] 1995,Molecular and Cellular Biochemistry(1-2):17~24
  • 4Yoram Shechter,Jingping Li,Joseph Meyerovitch,Dov Gefel,Rafael Bruck,Gerard Elberg,David S. Miller,Assia Shisheva. Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases[J] 1995,Molecular and Cellular Biochemistry(1-2):39~47
  • 5I. G. Fantus,G. Deragon,R. Lai,S. Tang. Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling[J] 1995,Molecular and Cellular Biochemistry(1-2):103~112

共引文献18

同被引文献19

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部